INDEPENDENT PERSPECTIVES ON WHOLE-PERSON HEALTHSearch the Journal ↗
Wholistic Health Journal
NEWS, PROVIDERS, AND DESTINATIONS FOR WHOLE-PERSON HEALTH
Sections & searchAll news & research
News
Health & Wellness TopicsFind a ProviderFeatured Providers by StateWellness DestinationsGet MatchedFor ProvidersSearch

Research explainer

In Mild Asthma, a Trial Counted Flare-Ups Between Prescriptions

Novel START compared three inhaler strategies in adults. Its main result concerns the rate of worsening asthma over a year, a different measure from immediate symptom relief.

Wholistic Health Journal ·

A metered-dose inhaler releases a spray.
A metered-dose inhaler releases a spray.
Wikip2011 · CC BY-SA 3.0 · Cropped to 8:5 and resized; converted to WebP.

Two jobs for an inhaler regimen

A person reaching for an inhaler during a spell of asthma symptoms may reasonably judge it by how quickly breathing feels easier. The investigators behind Novel START stepped back from that moment. They asked how often asthma worsened over the course of a year when adults with mild asthma were assigned different ways of using inhaled medicines. The distinction matters because relief during one episode and prevention of another are separate jobs. A trial that counts worsening episodes can tell us something that a patient's impression immediately after a dose cannot.

Three ways to organize treatment

The trial randomly assigned adults to three groups. One used albuterol when symptoms called for relief. Another used a scheduled inhaled corticosteroid, budesonide, and had albuterol available for symptoms. The third used a combination of budesonide and formoterol when needed. In that group, the act of responding to symptoms also delivered an anti-inflammatory medicine. The investigators monitored inhaler use electronically. Participants and clinicians knew which regimen they had received, a feature that brings the experience closer to ordinary prescribing but leaves room for expectations and behavior to influence the comparison.

Counting events across a year

The analysis included 668 adults. The annualized rate of exacerbations was 0.195 with the as-needed combination and 0.400 with as-needed albuterol. In more familiar units, those averages correspond to approximately 20 and 40 exacerbations per hundred patient-years. A rate counts episodes across the time people contribute to a study. It does not directly tell an individual their chance of an attack. A person with repeated episodes can contribute more than once, while another person can contribute a year of observation without experiencing one.

What is on the prescription?

A reader who knows their inhaler mainly by its color has little basis for mapping it onto these results. The comparison depends on the ingredients, the device and whether a medicine was prescribed for regular use or for symptoms. It concerned specific regimens in adults with mild asthma over 52 weeks. It cannot establish that every combination inhaler can serve as a reliever or that someone with a different prescription should change it independently. For a discussion with a prescriber, the study adds a second question alongside how well a medicine relieves symptoms today. Which part of the prescribed regimen is intended to reduce the next exacerbation?

Sources & references

Photo: Wikip2011 · CC BY-SA 3.0

Continue exploring

Related topic · Find a provider · Explore destinations

Stay informed